» Articles » PMID: 16631163

Human Progenitor Cells Isolated from the Developing Cortex Undergo Decreased Neurogenesis and Eventual Senescence Following Expansion in Vitro

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2006 Apr 25
PMID 16631163
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Isolation of a true self-renewing stem cell from the human brain would be of great interest as a reliable source of neural tissue. Here, we report that human fetal cortical cells grown in epidermal growth factor expressed low levels of telomerase and telomeres in these cultures shortened over time leading to growth arrest after 30 weeks. Following leukemia inhibitory factor (LIF) supplementation, growth rates and telomerase expression increased. This was best demonstrated following cell cycle synchronization and staining for telomerase using immunocytochemistry. This increase in activity resulted in the maintenance of telomeres at approximately 7 kb for more than 60 weeks in vitro. However, all cultures displayed a lack of oligodendrotye production, decreases in neurogenesis over time and underwent replicative senescence associated with increased expression of p21 before 70 weeks in vitro. Thus, under our culture conditions, these cells are not stable, multipotent, telomerase expressing self-renewing stem cells. They may be more accurately described as human neural progenitor cells (hNPC) with limited lifespan and bi-potent potential (neurons/astrocytes). Interestingly, hNPC follow a course of proliferation, neuronal production and growth arrest similar to that seen during expansion and development of the human cortex, thus providing a possible model neural system. Furthermore, due to their high expansion potential and lack of tumorogenicity, these cells remain a unique and safe source of tissue for clinical transplantation.

Citing Articles

Cellular and transcriptomic changes by the supplementation of aged rat serum in human pluripotent stem cell-derived myogenic progenitors.

Tey S, Anderson R, Yu C, Robertson S, Kletzien H, Connor N Front Cell Dev Biol. 2024; 12:1481491.

PMID: 39474351 PMC: 11518775. DOI: 10.3389/fcell.2024.1481491.


Cell therapy for neurological disorders.

Svendsen S, Svendsen C Nat Med. 2024; 30(10):2756-2770.

PMID: 39407034 DOI: 10.1038/s41591-024-03281-3.


Induced Pluripotent Stem Cell-Derived Extracellular Vesicles Promote Wound Repair in a Diabetic Mouse Model via an Anti-Inflammatory Immunomodulatory Mechanism.

Levy D, Nourmohammadi Abadchi S, Shababi N, Ravari M, Pirolli N, Bergeron C Adv Healthc Mater. 2023; 12(26):e2300879.

PMID: 37335811 PMC: 10592465. DOI: 10.1002/adhm.202300879.


Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration.

Laperle A, Moser V, Avalos P, Lu B, Wu A, Fulton A Stem Cell Reports. 2023; 18(8):1629-1642.

PMID: 37084724 PMC: 10444557. DOI: 10.1016/j.stemcr.2023.03.016.


Induced pluripotent stem cell-derived extracellular vesicles promote wound repair in a diabetic mouse model via an anti-inflammatory immunomodulatory mechanism.

Levy D, Nourmohammadi Abadchi S, Shababi N, Ravari M, Pirolli N, Bergeron C bioRxiv. 2023; .

PMID: 36993554 PMC: 10055496. DOI: 10.1101/2023.03.19.533334.